90 related articles for article (PubMed ID: 7762068)
1. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
Chahine AA; Yu M; McKernan MM; Stoeckert C; Lau HT
Transplantation; 1995 May; 59(9):1313-8. PubMed ID: 7762068
[TBL] [Abstract][Full Text] [Related]
2. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
[TBL] [Abstract][Full Text] [Related]
3. A self-immunomodulating myoblast cell line for erythropoietin delivery.
Schneider BL; Peduto G; Aebischer P
Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
5. Local CTLA4Ig synergizes with one-dose anti-LFA-1 to achieve long-term acceptance of pancreatic islet allografts.
Chahine AA; Yu M; McKernan M; Stoeckert C; Linsley PS; Lau HT
Transplant Proc; 1994 Dec; 26(6):3296. PubMed ID: 7998139
[No Abstract] [Full Text] [Related]
6. Anti-LFA-1 improves pig islet xenograft function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L.
Kumagai-Braesch M; Ekberg H; Wang F; Osterholm C; Ehrnfelt C; Sharma A; Lindeborg E; Holgersson J; Corbascio M
Transplantation; 2007 May; 83(9):1259-67. PubMed ID: 17496544
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
Steurer W; Nickerson PW; Steele AW; Steiger J; Zheng XX; Strom TB
J Immunol; 1995 Aug; 155(3):1165-74. PubMed ID: 7543517
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.
Levisetti MG; Padrid PA; Szot GL; Mittal N; Meehan SM; Wardrip CL; Gray GS; Bruce DS; Thistlethwaite JR; Bluestone JA
J Immunol; 1997 Dec; 159(11):5187-91. PubMed ID: 9548454
[TBL] [Abstract][Full Text] [Related]
10. In situ protection against islet allograft rejection by CTLA4Ig transduction.
Londrigan SL; Sutherland RM; Brady JL; Carrington EM; Cowan PJ; d'Apice AJ; O'Connell PJ; Zhan Y; Lew AM
Transplantation; 2010 Nov; 90(9):951-7. PubMed ID: 20808263
[TBL] [Abstract][Full Text] [Related]
11. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
Lakkis FG; Konieczny BT; Saleem S; Baddoura FK; Linsley PS; Alexander DZ; Lowry RP; Pearson TC; Larsen CP
J Immunol; 1997 Mar; 158(5):2443-8. PubMed ID: 9036995
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
[TBL] [Abstract][Full Text] [Related]
13. Combined costimulation blockade prevents rejection of allogeneic islets in mice.
Malm H; Påhlman C; Veress B; Corbascio M; Ekberg H
Scand J Immunol; 2006 Oct; 64(4):398-403. PubMed ID: 16970681
[TBL] [Abstract][Full Text] [Related]
14. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat.
Uchikoshi F; Yang ZD; Rostami S; Yokoi Y; Capocci P; Barker CF; Naji A
Diabetes; 1999 Mar; 48(3):652-7. PubMed ID: 10078573
[TBL] [Abstract][Full Text] [Related]
15. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
Onodera K; Chandraker A; Schaub M; Stadlbauer TH; Korom S; Peach R; Linsley PS; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 1997 Aug; 159(4):1711-7. PubMed ID: 9257832
[TBL] [Abstract][Full Text] [Related]
16. Effects of gene transfer CTLA4Ig and anti-CD40L monoclonal antibody on islet xenograft rejection in mice.
Zhang J; Li H; Jiang N; Zhang Q; Wang GS; Yi HM; Fu BS; Wang GY; Yang Y; Chen GH
Transplant Proc; 2010 Jun; 42(5):1835-7. PubMed ID: 20620534
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.
Akamaru Y; Ito T; Uchikoshi F; Maeda A; Tori M; Kiyomoto T; Komoda H; Miao G; Matsuda H
Transpl Immunol; 2003; 11(1):91-100. PubMed ID: 12727480
[TBL] [Abstract][Full Text] [Related]
18. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen.
Lew AM; Brady JL; Silva A; Coligan JE; Georgiou HM
Transplantation; 1996 Jul; 62(1):83-9. PubMed ID: 8693551
[TBL] [Abstract][Full Text] [Related]
19. Blockade of OX40 signals enhance survival of xenoislet grafts in spontaneously diabetic NOD mice.
Honkanen-Scott M; Johnson J; Hering B; Bansal-Pakala P
Transplant Proc; 2008 Mar; 40(2):483-5. PubMed ID: 18374109
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
